…Background Aging is the strongest independent risk factor for pancreatic ductal adenocarcinoma (PDAC) and is associated with worse clinical outcomes. As the global p…
Pancreatic Ductal Adenocarcinoma (PDAC)
This disease is selected. Its supporting articles are shown below.
Articles mentioning Pancreatic Ductal Adenocarcinoma (PDAC)
43 articles · page 3 of 4…Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with distinct tumor biology t…
…Background Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer and closely associated with cachexia. C…
…Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease characterized by early liver metastases. Ch…
…Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and treatment-resistant solid tum…
…Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive, poorly immunogenic cancer that is highly refr…
…urrence rate and highly heterogeneous tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) make it difficult for conventional therapies to achieve persona…
…Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease for which 5-year overall survival of e…
…Background Pancreatic ductal adenocarcinoma (PDAC) remains an indication of immense clinical need. KRAS mutation i…
…nt; however, their impact on obesity-associated cancers such as pancreatic ductal adenocarcinoma (PDAC) remains poorly understood. We previously demonstrated in precli…
…erse the immunologically ‘cold’ tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) remains clinically unsuccessful, warranting novel therapeutic s…
…Background Pancreatic ductal adenocarcinoma (PDAC) has poor survival which can be attributed to the highly immunos…